KEYNOTE-867: Phase 3, Randomized, Placebo-Controlled Study of Stereotactic Body Radiotherapy (SBRT) with or without Pembrolizumab in Patients with Unresected Stage I or II Non–Small-Cell Lung Cancer (NSCLC)

Autor: S.K. Jabbour, B. Houghton, A.G. Robinson, X. Quantin, T. Wehler, D. Kowalski, M.J. Ahn, M. Erman, G. Giaccone, H. Borghaei, J. McLean, Y. Xu, F. Souza, G. Pall
Rok vydání: 2022
Předmět:
Zdroj: International Journal of Radiation Oncology*Biology*Physics. 114:e376-e377
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2022.07.1516
Databáze: OpenAIRE